<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04294017</url>
  </required_header>
  <id_info>
    <org_study_id>1496/2017</org_study_id>
    <nct_id>NCT04294017</nct_id>
  </id_info>
  <brief_title>CellAdhesionMolecule EndometriosisRatio - CAMERA</brief_title>
  <acronym>CAMERA</acronym>
  <official_title>The Soluble VCAM-1 / Soluble ICAM-1 Ratio as a Non-invasive Biomarker for Diagnosing Endometriosis - a Prospective Multicenter Validation Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heinrich Husslein</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medical-Scientific Fund of the Mayor of the Federal Capital Vienna</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: Endometriosis, which is characterized by the growth of endometrial stroma and
      glands outside of the uterine cavity, is estimated to occur in 6-10% of women of reproductive
      age. Clinical presentation of endometriosis can vary widely, often significantly reducing
      quality of life, and the mean interval between the onset of symptoms and obtaining a
      definitive diagnosis is approximately 10 years. Currently, laparoscopy is the gold standard
      for diagnosing endometriosis; however, this procedure is invasive, carries surgery-related
      risks, and contributes to diagnostic delay. Therefore, the field has an urgent need for an
      efficient, sensitive, non-invasive tool for diagnosing endometriosis.

      Recently, it was shown that sVCAM-1/sICAM-1 ratio is a promising serum biomarker, which may
      lead to the development of a new, efficient, sensitive, non-invasive tool for diagnosing
      endometriosis, thereby potentially avoiding surgical interventions.

      Primary aim: To determine whether the serum sVCAM-1/sICAM-1 ratio can be used todiagnose
      endometriosis.

      Study design: Prospective multicenter validation study
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Months</target_duration>
  <primary_outcome>
    <measure>sICAM and sVCAM in serum</measure>
    <time_frame>up to 1 week</time_frame>
    <description>levels of these two soluble adhesion factors in serum of patients and controls</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Endometriosis (Diagnosis)</condition>
  <condition>Identification of Biomarkers in Serum</condition>
  <arm_group>
    <arm_group_label>patients</arm_group_label>
    <description>participants undergoing a diagnostic laparoscopy and have a histologically confirmed Endometriosis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>controls</arm_group_label>
    <description>participants undergoing a diagnostic laparoscopy where no evidence of Endometriosis could be found</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Up to 4 ml of serum per participant
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        women in reproductive age undergoing a diagnostic laparoscopy
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  unfulfilled desire for children

          -  chronic pelvic pain

          -  suspicion of endometriosis

          -  cysts

          -  myomas

        Exclusion Criteria:

          -  acute infections

          -  malign diseases

          -  drug abuse

          -  pregnancy

          -  infectious diseases
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Lorenz Kuessel, Dr.</last_name>
    <phone>+4314040049160</phone>
    <email>lorenz.kuessel@meduniwien.ac.at</email>
  </overall_contact>
  <location>
    <facility>
      <name>Medical University Vienna</name>
      <address>
        <city>Vienna</city>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lorenz Kuessel, Dr.</last_name>
      <phone>+434040049160</phone>
      <email>lorenz.kuessel@meduniwien.ac.at</email>
    </contact>
    <contact_backup>
      <last_name>Heinrich Husslein, Dr.</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>January 24, 2020</study_first_submitted>
  <study_first_submitted_qc>March 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 3, 2020</study_first_posted>
  <last_update_submitted>March 2, 2020</last_update_submitted>
  <last_update_submitted_qc>March 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 3, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Heinrich Husslein</investigator_full_name>
    <investigator_title>Assoc.Prof.Priv.Doz Dr.med.univ. , PLL.M.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Endometriosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

